Arcadia Biosciences, Inc.
NASDAQ Capital MarketCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.Company Description
- CEO
- Thomas J. Schaefer
- Full Time Employees
- 8
- Sector
- Basic Materials
- Industry
- Agricultural Inputs
- Address
- 5956 Sherry Lane Davis TX United States of America 75225
- IPO Date
- May 15, 2015
- CIK
- 0001469443
- Website
- arcadiabio.com
- Similar Companies
- Business
- Arcadia Biosciences, Inc. (Nasdaq: RKDA) produces and markets plant-based health and wellness products, including specialty crop ingredients and branded consumer goods, in the United States. The company develops advanced wheat improvements under the GoodWheat brand, offering high-fiber, reduced-gluten, high-protein, and low-calorie flours and ingredients with extended shelf life that enhance nutritional profiles and farm economics; Zola coconut water in original, pulp, espresso, lime, and pineapple flavors as a natural, low-calorie hydration product sourced from Thailand; and other wellness offerings such as ProVault topical pain relief and SoulSpring body care products. Founded in 2002 and headquartered in Dallas, Texas, Arcadia Biosciences operates primarily in the consumer staples sector, targeting food manufacturers, processors, and retail consumers with functional foods and beverages. In December 2024, the company entered a definitive all-stock business combination agreement with Roosevelt Resources LP, under which Arcadia will issue shares representing approximately 90% post-closing ownership to Roosevelt partners in exchange for its equity interests, shifting strategic focus toward oil and gas field development in the RR-Googins field while streamlining prior operations around Zola and GoodWheat.
Company News
Analyzing Arcadia Biosciences (NASDAQ:RKDA) & Molson Coors Beverage (NYSE:TAP.A)
Arcadia Biosciences (NASDAQ:RKDA) and Kirin (OTCMKTS:KNBWY) Financial Survey
Arcadia Biosciences (RKDA) Announces Second Quarter and First Half 2026 Financial Results and Business Highlights
Arcadia Biosciences (NASDAQ:RKDA) versus Diageo (NYSE:DEO) Critical Comparison
Arcadia Biosciences (RKDA) Announces Closing of $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules
Arcadia Biosciences (RKDA) Announces Closing of $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules
Arcadia Biosciences (RKDA) Announces $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules
Arcadia Biosciences (RKDA) Announces $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules
Arcadia Biosciences (RKDA) Announces First Quarter 2026 Financial Results and Business Highlights
Arcadia Biosciences (RKDA) Announces Fourth-Quarter and Full-Year 2025 Financial Results and Business Highlights
Arcadia Biosciences (RKDA) Announces Exercise of Preferred Investment Options for $2.1 Million Gross Proceeds
Arcadia Biosciences (RKDA) Receives Termination Notice of the Proposed Business Combination with Roosevelt Resources
Arcadia Biosciences (NASDAQ:RKDA) Shares Cross Below Fifty Day Moving Average – Here’s Why
Arcadia Biosciences (RKDA) Announces Third Quarter 2025 Financial Results and Business Highlights
Arcadia Biosciences (RKDA) Announces Second Quarter and First Half 2025 Financial Results and Business Highlights
Arcadia Biosciences, Inc. (RKDA) Q1 2025 Earnings Call Transcript
Arcadia Biosciences (RKDA) Announces First Quarter 2025 Financial Results and Business Highlights
Arcadia Biosciences (RKDA) Announces Date of First Quarter 2025 Financial Results and Business Highlights Conference Call
Arcadia Biosciences, Inc (RKDA) Q4 2024 Earnings Call Transcript
Arcadia Biosciences (RKDA) Announces Fourth-Quarter and Full-Year 2024 Financial Results and Business Highlights